Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-01-28 RUBINSTEIN JULIE President Sale −3,433 $54.96 $189K 10,567
2021-01-28 RUBINSTEIN JULIE President Sale −9,420 $55.96 $527K 2,147
2021-01-28 RUBINSTEIN JULIE President Sale −2,147 $56.68 $122K 0
2021-01-28 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 110,000
2021-01-28 ROBINS CHAD M CEO and Chairman Sale −600 $55.01 $33K 1,749,180
2021-01-28 ROBINS CHAD M CEO and Chairman Sale −2,800 $55.94 $157K 1,746,380
2021-01-28 ROBINS CHAD M CEO and Chairman Sale −4,300 $57.32 $246K 1,742,080
2021-01-28 ROBINS CHAD M CEO and Chairman Sale −2,300 $57.83 $133K 1,739,780
2021-01-27 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2021-01-27 RUBINSTEIN JULIE President Sale −6,387 $58.19 $372K 8,613
2021-01-27 RUBINSTEIN JULIE President Sale −6,913 $59.37 $410K 1,700
2021-01-27 RUBINSTEIN JULIE President Sale −1,700 $59.99 $102K 0
2021-01-27 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 125,000
2021-01-27 BALDO LANCE Chief Medical Officer Option exercise +40,000 $7.80 $312K 40,000
2021-01-27 BALDO LANCE Chief Medical Officer Sale −17,499 $58.22 $1.0M 22,501
2021-01-27 BALDO LANCE Chief Medical Officer Sale −14,233 $59.24 $843K 8,268
2021-01-27 BALDO LANCE Chief Medical Officer Sale −8,268 $60.01 $496K 0
2021-01-27 BALDO LANCE Chief Medical Officer Option exercise · Stock Option (Right to Buy) −40,000 341,250
2021-01-27 ROBINS CHAD M CEO and Chairman Sale −1,879 $54.63 $103K 1,757,901
2021-01-27 ROBINS CHAD M CEO and Chairman Sale −1,000 $56.26 $56K 1,756,901

Page 66 of 120 · 2,386 trades